Paclitaxel-bevacizumab in Advanced Lung Cancer

NCT01763671 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

166

Enrollment

OTHER

Sponsor class

Conditions

Non-squamous Non-small Cell Lung Cancer

Interventions

DRUG: Docetaxel
DRUG: Paclitaxel
DRUG: Bevacizumab

Sponsor

Intergroupe Francophone de Cancerologie Thoracique